AtriCure (ATRC) reported a Q4 adjusted net loss late Wednesday of $0.08 per diluted share, narrowing from a loss of $0.21 a year earlier.
Analysts surveyed by FactSet expected a loss of $0.16.
Revenue for the quarter ended Dec. 31 was $124.3 million, up from $106.5 million a year earlier.
Analysts surveyed by FactSet expected $121.3 million.
For full-year 2025, the company said it expects adjusted loss per share of between $0.57 and $0.64, and revenue of roughly $517 million to $527 million. Analysts surveyed by FactSet expect a loss of $0.60 and revenue of $522.3 million.
Shares of the company were down 4.5% in recent after-hours activity.
Price: 40.44, Change: -1.92, Percent Change: -4.53
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。